Premium
Contrasting immunopathogenic properties of highly homologous peptides‘qc from rat and human thyroglobulin
Author(s) -
RAO V. P.,
CARAYANNIOTIS G.
Publication year - 1997
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1046/j.1365-2567.1997.00160.x
Subject(s) - epitope , heterologous , biology , thyroglobulin , homology (biology) , amino acid , peptide sequence , t cell , microbiology and biotechnology , immunology , antigen , immune system , genetics , antibody , gene
The current lack of amino acid sequence data for mouse thyroglobulin (Tg) necessitates mapping of pathogenic T‐cell epitopes on heterologous Tg in mouse experimental autoimmune thyroiditis (EAT). A prevailing assumption has been that epitopes sharing a high degree of amino acid homology among heterologous Tg are likely to exhibit the same immunopathogenic properties in the same host. In this report, we have examined this concept while working with the 18‐mer rat(r)Tg(2695–13) peptide that was previously shown to elicit A s ‐restricted T cells and EAT in SJL mice. A major immunopathogenic T‐cell epitope was localized within the 12‐mer rTg(2695–06). It was found that the human 12‐mer homologue that carries two Ser substitutions at Glu2703 and Thr2704 exhibited contrasting properties: it failed to activate Th1 cells in lymphokine and proliferation assays; it did not cross‐react with rTg(2695–06) at the T‐cell level; and it induced only focal thyroiditis following adoptive transfer of specific lymph node cells. These data highlight the caveat involved in extrapolating results of pathogenic T‐cell epitope mapping across heterologous Tgs, even when such epitopes share a high degree of amino acid homology.